Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | HTT | P42858 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | NPY1R | P25929 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37086 | 0.95 | ALDH1A1 (0.37) | L3MBTL1MAPTALDH1A1KDM4ECYP1A2 | |
| SCHEMBL18561896 | 0.95 | ALDH1A1 (0.37) | L3MBTL1MAPTALDH1A1KDM4ECYP1A2 | |
| SCHEMBL13806963 | 0.94 | L3MBTL1 (0.36) | L3MBTL1MAPTALDH1A1KDM4ECYP1A2 | |
| SCHEMBL13806941 | 0.94 | L3MBTL1 (0.36) | L3MBTL1MAPTALDH1A1KDM4ECYP1A2 | |
| SCHEMBL9963820 | 0.92 | L3MBTL1 (0.35) | L3MBTL1MAPTALDH1A1KDM4ECYP1A2 | |
| SCHEMBL761434 | 0.87 | PTAFR (0.33) | L3MBTL1MAPTALDH1A1KDM4ETDP1 | |
| SCHEMBL10063894 | 0.87 | ALDH1A1 (0.38) | L3MBTL1MAPTALDH1A1KDM4ECYP1A2 | |
| SCHEMBL13615687 | 0.86 | ALDH1A1 (0.41) | L3MBTL1MAPTALDH1A1KDM4ECYP1A2 | |
| SCHEMBL12337529 | 0.86 | ALDH1A1 (0.41) | L3MBTL1MAPTALDH1A1KDM4ECYP1A2 | |
| SCHEMBL14099683 | 0.86 | ALDH1A1 (0.41) | L3MBTL1MAPTALDH1A1KDM4ECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153279-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2012-04-10 | — | — | US | disclosed |
| US-8153279-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2012-04-10 | — | — | US | disclosed |
| US-7906228-B2 | Compounds for electronic material and organic electronic device using the same | GRACEL DISPLAY INC. (KR) | 2011-03-15 | — | — | US | disclosed |
| US-7906228-B2 | Compounds for electronic material and organic electronic device using the same | GRACEL DISPLAY INC. (KR) | 2011-03-15 | — | — | US | disclosed |
| US-7888863-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2011-02-15 | — | — | US | disclosed |
| US-7888863-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2011-02-15 | — | — | US | disclosed |
| EP-2062958-B1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC (KR) | 2010-07-28 | — | — | EP | disclosed |
| WO-2010058995-A1 | ELECTROLUMINESCENT DEVICE USING THE ELECTROLUMINESCENT COMPOUNDS | GRACEL DISPLAY INC. (KR) | 2010-05-27 | — | — | WO | disclosed |
| EP-2189508-A2 | Electroluminescent device using electroluminescent compounds | Gracel Display Inc. (KR) | 2010-05-26 | — | — | EP | disclosed |
| EP-2066150-B1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC (KR) | 2010-05-26 | — | — | EP | disclosed |
| US-20090153040-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-18 | — | — | US | disclosed |
| US-20090153040-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-18 | — | — | US | disclosed |
| US-20090153037-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-18 | — | — | US | disclosed |
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | GRACEL DISPLAY INC. (KR) | 2009-06-11 | — | — | US | disclosed |
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | GRACEL DISPLAY INC. (KR) | 2009-06-11 | — | — | US | disclosed |
| EP-2066150-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-06-03 | — | — | EP | disclosed |
| EP-2062958-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-27 | — | — | EP | disclosed |
| EP-2060579-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-20 | — | — | EP | disclosed |
| EP-2058322-A2 | Novel red electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-13 | — | — | EP | disclosed |
| EP-2055709-A2 | Novel red electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | LEF1, ODC1, AOC2 | L3MBTL1 2144/4885MAPT 2579/4885ALDH1A1 5/4885 |
| US-20090153040-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, APOL1 | L3MBTL1 315/4885MAPT 1411/4885ALDH1A1 139/4885 |
| US-20090153037-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | NDUFS2, ALDH1A2, ODC1 | L3MBTL1 3164/4885MAPT 1708/4885ALDH1A1 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.